arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CATALYST PHARMACEUTICALS, INC.

CPRX

$31.49 0.00 (0.00%) at close

25 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

CATALYST PHARMACEUTICALS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $3.9B

Dividend Yield —

Revenue Growth 19.8% ↘

Op. Margin 43.8% ↗

ROIC 20.4% →

FCF / Share $1.71 ↘

Trailing P/E 18.0x

Price / Book 4.0x

FCF Yield 5.4%

Debt / Equity —

info Valuation on last close. End-of-day price, Jul 14, 2026.

25-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$588.99M

↑ +19.8% —

Net Income Profit after all expenses

$214.33M

↑ +30.8% —

Operating Margin Operating profit as % of sales

43.8%

↑ +10.3% 95th

FCF / Share Free cash flow per share

$1.71

↓ -15.5% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Revenue Growth YoY (%)	19.8% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+147%)	23.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+194%)	85.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+974%)	52.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+551%)	18.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+128%)	16.4% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+105%)	20361.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+254416%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	26.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	106.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-16.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	110.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-47.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	132.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	30.8% Excellent ↓ Excellent Declining Year-over-year change in net income	129.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.0% Weak ↓ Weak Declining Year-over-year change in net income	110.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-47.3% Weak ↓ Weak Declining Year-over-year change in net income	135.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-84.7% Weak ↓ Weak Declining Year-over-year change in net income	-1.9% Weak ↑ Weak Improving Year-over-year change in net income	10.7% Fair ↑ Fair Improving Year-over-year change in net income	-30.5% Weak ↑ Weak Improving Year-over-year change in net income	-27.6% Weak ↑ Weak Improving Year-over-year change in net income	-198.2% Weak ↓ Weak Declining Year-over-year change in net income	36.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-59.5% Weak ↓ Weak Declining Year-over-year change in net income	44.7% Excellent ↑ Excellent Improving Year-over-year change in net income	31.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-155.2% Weak ↓ Weak Declining Year-over-year change in net income	-51.7% Weak ↑ Weak Improving Year-over-year change in net income	-51.2% Weak ↑ Weak Improving Year-over-year change in net income	-234.4% Weak ↓ Weak Declining Year-over-year change in net income	-25.9% Weak Weak Year-over-year change in net income	-67.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-15.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	49.7% Excellent → Excellent Stable Year-over-year change in free cash flow	20.2% Good ↓ Good Declining Year-over-year change in free cash flow	95.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	32.0% Excellent Excellent Year-over-year change in free cash flow	29.4% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	40.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	49.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	27.9% Excellent Excellent Compound annual revenue growth over 3 years	555.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	37.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	36.9% Excellent Excellent Compound annual revenue growth over 5 years	280.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	29.8% Excellent → Excellent Stable Compound annual EPS growth over 3 years	53.7% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	-2.4% Weak Weak Compound annual EPS growth over 3 years	37.2% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Operating Margin (%) (%)	43.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+192%)	39.7% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+165%)	21.8% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+45%)	47.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+217%)	37.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+148%)	34.7% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+131%)	31.1% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+107%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	24.4% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.2% Fair → Fair Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.4% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.7% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	25.0% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-79.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	36.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+203%)	33.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+178%)	17.9% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+49%)	38.8% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+223%)	28.0% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+134%)	63.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+425%)	31.2% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+160%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	35.4% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	48.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	36.0% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	54.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	42.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	37.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	33.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.97x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.46x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	2.01x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.40x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Return on Invested Capital (%)	20.4% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	20.3% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	16.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	26.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	43.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	34.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-54.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-41.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-127.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-75.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	23.3% Excellent → Excellent Stable Operating profit relative to total assets Optimal: > 10%	22.9% Excellent → Excellent Stable Operating profit relative to total assets Optimal: > 10%	18.5% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	27.1% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	22.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	21.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	28.3% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-58.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-97.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-69.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	22.5% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+50%)	22.5% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+50%)	18.4% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+23%)	27.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+84%)	19.1% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+27%)	44.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+195%)	36.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+142%)	-67.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-546%)	-22.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-46.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-407%)	-36.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-44.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-56.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-479%)	-27.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-169.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1233%)	-72.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-584%)	-95.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-734%)	-100.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-767%)	-25.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	-13.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	—	—	-118.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-888%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Interest Coverage (x)	553.17x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	139.87x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	123.14x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-709.17M	$-517.55M	$-137.64M	$-298.39M	$-171.44M	$-130.24M	$-89.51M	$-16.56M	$-57.50M	$-13.89M	$-28.24M	$-9.10M	$-2.22M	$-1.41M	$-6.03M	$-5.48M	$-7.78M	$-11.77M	—	—	—	—	—	—	$-100.00K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Revenue per Share (USD)	$4.82	$4.15	$3.75	$2.07	$1.36	$1.15	$0.99	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$1.75	$1.38	$0.67	$0.80	$0.38	$0.72	$0.31	$-0.33	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$1.71	$2.02	$1.35	$1.12	$0.57	$0.43	$0.34	$-0.26	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$7.79	$6.02	$3.62	$2.85	$2.01	$1.63	$0.85	$0.49	$0.79	$0.47	$0.67	$0.51	$0.40	$0.35	$0.15	$0.28	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$7.79	$6.02	$3.62	$2.85	$2.01	$1.63	$0.85	$0.49	$0.79	$0.47	$0.67	$0.51	$0.40	$0.35	$0.15	$0.28	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	122.29M	118.46M	106.28M	103.37M	103.38M	103.51M	102.94M	102.63M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Working Capital (USD)	$746.88M	$502.93M	$143.27M	$263.22M	$183.04M	$136.49M	$87.26M	$45.68M	$80.92M	$39.36M	$56.46M	$37.97M	$23.18M	$15.08M	$5.39M	$5.48M	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$954.27M	$727.63M	$387.88M	$300.42M	$206.83M	$169.60M	$87.63M	$50.78M	$80.96M	$39.31M	$55.48M	$35.24M	$21.39M	$14.62M	$3.76M	$5.52M	$7.62M	$10.56M	$16.32M	$19.85M	$446.46K	$117.58K	$362.56K	$44.89K	$100.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Jan 4, 2002 10-K ↗
Sales/Revenue/Turnover (USD)	$588.99M	$491.73M	$398.20M	$214.20M	$140.83M	$119.07M	$102.31M	$500.00K	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$375.00K	$397.00K	$316.00K	$141.00K	$192.00K	$92.06K	$54.33K	$37.98K	$45.69K	$43.41K	$34.47K	$26.57K	$22.48K	$10.89K	$42.84K	$25.74K	$30.23K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$214.33M	$163.89M	$71.41M	$83.08M	$39.48M	$74.98M	$31.88M	$-34.00M	$-18.41M	$-18.07M	$-20.23M	$-15.51M	$-12.15M	$-4.08M	$-6.39M	$-4.01M	$-7.24M	$-10.56M	$-4.14M	$-2.73M	$-1.81M	$-539.82K	$-428.62K	$-255.94K	—
Operating Cash Flow (USD)	$208.67M	$239.81M	$143.60M	$116.05M	$60.37M	$45.03M	$34.61M	$-26.15M	$-13.74M	—	—	—	—	$-5.14M	$-4.99M	$-3.76M	$-7.68M	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 25 years · 75 quarters

CATALYST PHARMACEUTICALS, INC.

Analytical Summary

25-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CPRX with peers